Study the Effect of Probiotics Combined With Bismuth Quadruple Rescue Therapy on H Pylori Infective Patients
NCT03297242 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2017-12-07
Summary
Retrospectivly follow-up the outpatients for H pylori eradication failures more than 2 times in the digestive department of Changhai hospital from 2015-2017,analyse the eradication rates and adverse effects of the therapy with 2w's compound lactobacillus acidophilus followed by 10d's bismuth, furazolidone, tetracycline contained quadruple scheme.
Conditions
- Helicobacter Pylori Infection
Sponsors & Collaborators
-
Changhai Hospital
lead OTHER
Principal Investigators
-
Zhao S Li, MD
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-12-31
- Primary Completion
- 2018-09-30
- Completion
- 2018-09-30
More Related Trials
-
Eradication Efficacy and Safety of Two Rescue Treatments for Helicobacter Pylori Infection
NCT05176821 ·Status: UNKNOWN ·Phase: NA
-
Levofloxacin and Bismuth-containing Therapy Versus Quadruple Therapy as Second-line Treatment of Resistant Helicobacter Pylori Infection
NCT01742429 ·Status: COMPLETED ·Phase: PHASE4
-
Helicobacter Rescue Therapy With High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy
NCT04678492 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of a 14-Day Bismuth-Containing Quadruple Therapy Guided by Drug Susceptibility Testing in Patients with Extremely Refractory Helicobacter Pylori Infection: an Exploratory Study
NCT06731023 ·Status: NOT_YET_RECRUITING
-
Helicobacter Pylori Eradication With Clostridum Butyricum Capsule and Bacillus Coagulans Tablets
NCT03857425 ·Status: COMPLETED ·Phase: PHASE4
-
Second Line Bismuth Containing Quadruple Therapy With Supplementary Probiotic
NCT05577572 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Time Intervals for Rescue Treatment on Eradication Effect of Helicobacter Pylori Infection
NCT05620589 ·Status: UNKNOWN
-
Low Dose Bismuth Versus Lactobacillus Reuteri for H. Pylori Eradication
NCT03925818 ·Status: TERMINATED ·Phase: NA
-
Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal Microecology
NCT05742568 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Bismuth Quadruple Therapy Containing Cefuroxime and Tetracycline as First-line Therapy for Eradicating Helicobacter Pylori in Patients Allergic to Penicillin
NCT06351891 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Therapy of Different Tetracycline Doses and Frequencies.
NCT05432115 ·Status: UNKNOWN ·Phase: PHASE4
-
Quadruple Therapy Versus Dual Therapy as Rescue Regimens for Helicobacter Pylori Infection
NCT01805934 ·Status: COMPLETED ·Phase: PHASE2
-
Optimal Duration of Antimicrobial Susceptibility Test (AST) Guided Rescue Therapy for Helicobacter Pylori Infection
NCT02934048 ·Status: UNKNOWN ·Phase: PHASE4
-
The Efficacy of 10-day and 14-day Bismuth-based Quadruple Therapy in First-line H. Pylori Eradication
NCT04527055 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
The Study About the Selection of Time for Retreatment of Helicobacter Pylori After Eradication Failure
NCT05173493 ·Status: COMPLETED
-
Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication
NCT05049902 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacies of HDDT With or Without Bismuth vs Amoxicillin-metronidazole BQT for First-line H Pylori Eradication
NCT03897244 ·Status: COMPLETED ·Phase: PHASE4
-
Efficiency Study of Clarithromycin and Bismuth-containing Quadruple Therapy to Treat H.Pylori
NCT01667575 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Tegoprazan Based Bismuth Quadruple Therapy for Helicobacter Pylori Infection
NCT04674774 ·Status: UNKNOWN ·Phase: NA
-
Study of the Usefulness of the Probiotic 'Lactobacillus Reuteri' in the Therapy of Quadruple Eradication of Helicobacter Pylori Infection in Usual Clinical Practice.
NCT03150394 ·Status: UNKNOWN ·Phase: PHASE4
-
A Real World Study of Bismuth Colloidal Pectin Granules Quadruple Therapy for H. Pylori Eradication
NCT04660123 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Therapy Based on Fecal Molecular Antimicrobial Susceptibility Tests for Helicobacter Pylori Infection
NCT05718609 ·Status: UNKNOWN ·Phase: PHASE4
-
Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment
NCT07139366 ·Status: RECRUITING ·Phase: PHASE4
-
The Effects of High-dose Dual Therapy With Probiotics on Gut Microbiota for Helicobacter Pylori Rescue Treatment
NCT06292546 ·Status: COMPLETED ·Phase: NA
-
Pilot Study of a 14-day Modified Sequential Therapy for Helicobacter Pylori Infection
NCT03616405 ·Status: UNKNOWN ·Phase: PHASE4